Related references
Note: Only part of the references are listed.6-Phenylpyrimidin-4-ones as Positive Allosteric Modulators at the M1 mAChR: The Determinants of Allosteric Activity
Manuela Jorg et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Probing the binding site of novel selective positive allosteric modulators at the M-1 muscarinic acetylcholine receptor
Elham Khajehali et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Synthesis and Pharmacological Evaluation of Heterocyclic Carboxamides: Positive Allosteric Modulators of the M1 Muscarinic Acetylcholine Receptor with Weak Agonist Activity and Diverse Modulatory Profiles
Juliana C. C. Dallagnol et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Assessment of the Molecular Mechanisms of Action of Novel 4-Phenylpyridine-2-One and 6-Phenylpyrimidin-4-One Allosteric Modulators at the M-1 Muscarinic Acetylcholine Receptors
Emma T. van der Westhuizen et al.
MOLECULAR PHARMACOLOGY (2018)
Design and Synthesis of γ- and δ-Lactarn M1 Positive Allosteric Modulators (PAMs): Convulsion and Cholinergic Toxicity of an M1-Selective PAM with Weak Agonist Activity
Jennifer E. Davoren et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Acetylcholinesterase Inhibitors and Drugs Acting on Muscarinic Receptors-Potential Crosstalk of Cholinergic Mechanisms During Pharmacological Treatment
Ondrej Soukup et al.
CURRENT NEUROPHARMACOLOGY (2017)
Diverse Effects on M1 Signaling and Adverse Effect Liability within a Series of 101 Ago-PAMs
Jerri M. Rook et al.
ACS CHEMICAL NEUROSCIENCE (2017)
4-Phenylpyridin-2-one Derivatives: A Novel Class of Positive Allosteric Modulator of the M1 Muscarinic Acetylcholine Receptor
Shailesh N. Mistry et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Novel Fused Arylpyrimidinone Based Allosteric Modulators of the M1 Muscarinic Acetylcholine Receptor
Shailesh N. Mistry et al.
ACS CHEMICAL NEUROSCIENCE (2016)
Further optimization of the M1 PAM VU0453595: Discovery of novel heterobicyclic core motifs with improved CNS penetration
Joseph D. Panarese et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Discovery of the Potent and Selective M1 PAM-Agonist N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects
Jennifer E. Davoren et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Crystal structures of the M1 and M4 muscarinic acetylcholine receptors
David M. Thal et al.
NATURE (2016)
Positive Allosteric Modulation of the Muscarinic M1 Receptor Improves Efficacy of Antipsychotics in Mouse Glutamatergic Deficit Models of Behavior
Kwok H. C. Choy et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
Molecular Determinants of Allosteric Modulation at the M1 Muscarinic Acetylcholine Receptor
Alaa Abdul-Ridha et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders
P. Jeffrey Conn et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Allosteric modulation of the M1 muscarinic acetylcholine receptor: improving cognition and a potential treatment for schizophrenia and Alzheimer's disease
Bruce J. Melancon et al.
DRUG DISCOVERY TODAY (2013)
Synthesis and Pharmacological Profiling of Analogues of Benzyl Quinolone Carboxylic Acid (BQCA) as Allosteric Modulators of the M1 Muscarinic Receptor
Shailesh N. Mistry et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
M1 muscarinic acetylcholine receptor allosteric modulators as potential therapeutic opportunities for treating Alzheimer's disease
Michael Decker et al.
MEDCHEMCOMM (2012)
Allosteric Modulators of the Adenosine A1 Receptor: Synthesis and Pharmacological Evaluation of 4-Substituted 2-Amino-3-benzoylthiophenes
Luigi Aurelio et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders
P. Jeffrey Conn et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation
Lei Ma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology
Katie Leach et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development
Juergen Wess et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Allosteric binding sites on cell-surface receptors: Novel targets for drug discovery
A Christopoulos
NATURE REVIEWS DRUG DISCOVERY (2002)
Share Paper
